Hard to work out how bigger compromises they have made on the programme’s . If the original studies were powered properly ( not overkill) I can only think that the results we have won’t be worth much in getting regulatory outcomes. Does this mean everything will need to be redone meaning huge delays and expense ? understand it’s out of their control but very disappointing and think they should have given us visibility of the revised timeline’s and budget impact if we have delays to commercialisation. already halved my money don’t want a CR. I am Moving to Hold from Buy
CP1 Price at posting:
10.0¢ Sentiment: Hold Disclosure: Held